The human epidermal growth factor receptor 2 (HER2) is an important biomarker for breast cancer prognosis and predictive efficacy of HER2-targeted therapy. According to the American Society of ...
Immunohistochemistry uses antibodies to test tissue samples for specific types of antigens. It can often provide very specific results regarding cancer types or other diseases, helping doctors decide ...
Distinguishing benign and malignant mesothelial proliferations can be difficult based on histology alone. Existing immunohistochemical markers that may aid in this distinction have limited sensitivity ...
Researchers from Lund University (Sweden) have investigated the tumor immune microenvironment of primary triple-negative breast cancer using digital image analysis of IHC-stained immune cells. To do ...
Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing The following ...
Boster Biological Technology, a life science reagent manufacturer based in Pleasanton, California, has broadened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results